CoChat

Venous and Arterial Endothelial Cells from Human Umbilical Cords: Potential Cell Sources for Cardiovascular Research

Open access
Lau, Skadi, Gossen, Manfred, Lendlein, Andreas, Jung, Friedrich · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Although cardiovascular devices are mostly implanted in arteries or to replace arteries, in vitro studies on implant endothelialization are commonly performed with human umbilical cord-derived venous endothelial cells (HUVEC). In light of considerable differences, both morphologically and functionally, between arterial and venous endothelial cells, we here compare HUVEC and human umbilical cord-derived arterial endothelial cells (HUAEC) regarding their equivalence as an endothelial cell in vitro model for cardiovascular research. No differences were found in either for the tested parameters. The metabolic activity and lactate dehydrogenase, an indicator for the membrane integrity, slightly decreased over seven days of cultivation upon normalization to the cell number. The amount of secreted nitrite and nitrate, as well as prostacyclin per cell, also decreased slightly over time. Thromboxane B2 was secreted in constant amounts per cell at all time points. The Von Willebrand factor remained mainly intracellularly up to seven days of cultivation. In contrast, collagen and laminin were secreted into the extracellular space with increasing cell density. Based on these results one might argue that both cell types are equally suited for cardiovascular research. However, future studies should investigate further cell functionalities, and whether arterial endothelial cells from implantation-relevant areas, such as coronary arteries in the heart, are superior to umbilical cord-derived endothelial cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22020978

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Morphology of endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. Phase contrast images were taken at 10-fold primary magnification. Cells developed the typical cobblestone-like morphology of mature endothelial cells with increasing proliferation time. Scale bar represents 100 µm.
Figure 1 Morphology of endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. Phase contrast images were taken at 10-fold primary magnification. Cells developed the typical cobblestone-like morphology of mature endothelial cells with increasing proliferation time. Scale bar represents 100 µm.CC BY · PubMed Central
Figure 2 Endothelial cell viability and density. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. Cell viability staining detected living (green) and dead (red) cells (A). Quantification of vital cells showed that only a few cells died over time (B). The cell density, expressed as the number of vital adherent cells per mm2, increased over time (C). Fluorescent images were taken at 10-fold primary magnification. Scale bar represents 100 µm, and 50 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified. Straight black lines indicate p ≤ 0.0099.
Figure 2 Endothelial cell viability and density. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. Cell viability staining detected living (green) and dead (red) cells (A). Quantification of vital cells showed that only a few cells died over time (B). The cell density, expressed as the number of vital adherent cells per mm2, increased over time (C). Fluorescent images were taken at 10-fold primary magnification. Scale bar represents 100 µm, and 50 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified. Straight black lines indicate p ≤ 0.0099.CC BY · PubMed Central
Figure 3 Metabolic activity (A) and membrane integrity (B) of endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. The metabolic activity and membrane integrity were normalized to the number of vital adherent cells per mm2 leading to decreasing values over time. Straight black lines indicate p ≤ 0.0058.
Figure 3 Metabolic activity (A) and membrane integrity (B) of endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. The metabolic activity and membrane integrity were normalized to the number of vital adherent cells per mm2 leading to decreasing values over time. Straight black lines indicate p ≤ 0.0058.CC BY · PubMed Central
Figure 4 Secretion of vasoactive substances by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. The amounts of the sum of nitrite and nitrate (A), prostacyclin (B), and thromboxane B2 (C) were quantified by ELISA and normalized to the number of vital adherent cells per mm2. While less nitrite/nitrate and prostacyclin were released over time, the amount of thromboxane B2 remained constant. Straight black lines indicate p ≤ 0.0063.
Figure 4 Secretion of vasoactive substances by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. The amounts of the sum of nitrite and nitrate (A), prostacyclin (B), and thromboxane B2 (C) were quantified by ELISA and normalized to the number of vital adherent cells per mm2. While less nitrite/nitrate and prostacyclin were released over time, the amount of thromboxane B2 remained constant. Straight black lines indicate p ≤ 0.0063.CC BY · PubMed Central
Figure 5 Expression of actin fibers by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. While most of the cells exhibited actin fibers throughout the cell body at day 2, an increasing number of cells with pronounced cortical actin fibers were present at day 4 and 7 (indicated by white arrows). Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm the in magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.
Figure 5 Expression of actin fibers by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. While most of the cells exhibited actin fibers throughout the cell body at day 2, an increasing number of cells with pronounced cortical actin fibers were present at day 4 and 7 (indicated by white arrows). Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm the in magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.CC BY · PubMed Central
Figure 6 Expression of von Willebrand factor (vWF) by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. Cells from both sources expressed vWF at all time points. At day 4 and 7, some extracellular vWF fibers were observed (white arrows). Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.
Figure 6 Expression of von Willebrand factor (vWF) by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. Cells from both sources expressed vWF at all time points. At day 4 and 7, some extracellular vWF fibers were observed (white arrows). Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.CC BY · PubMed Central
Figure 7 Expression of collagen I-V by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. While only traces of collagen were detected at day 2, the expression increased with increasing cultivation time, leading to large networks of collagen fibers at day 7 with cells from both sources. Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.
Figure 7 Expression of collagen I-V by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0 and cultivated for 2, 4, and 7 days. While only traces of collagen were detected at day 2, the expression increased with increasing cultivation time, leading to large networks of collagen fibers at day 7 with cells from both sources. Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.CC BY · PubMed Central
Figure 8 Expression of laminin by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. While laminin was only intracellularly present at day 2, it was secreted into the extracellular space with increasing cultivation time, leading to a wide fleece-like network at day 7. Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.
Figure 8 Expression of laminin by endothelial cells. Human umbilical cord-derived endothelial cells from veins (HUVEC) or arteries (HUAEC) were seeded at a density of 15,000 cells/well at day 0, and cultivated for 2, 4, and 7 days. While laminin was only intracellularly present at day 2, it was secreted into the extracellular space with increasing cultivation time, leading to a wide fleece-like network at day 7. Fluorescent images were taken at 20-fold primary magnification. Scale bar represents 50 µm, and 25 µm in the magnified image sections in the upper right corner of each image. Squares with dashed lines indicate the image region that was magnified.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 45

Metadata

Authors
Lau, S., Gossen, M., Lendlein, A., & Jung, F.
Affiliations
  • Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany
  • University of Potsdam (DE)
Corresponding author
  • Lendlein, Andreas
  • Jung, Friedrich
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-01-19
Volume
22
Issue
2
Pages
978
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3125630250
Cited by
38
References
38
Citations by year
2026: 3 · 2025: 8 · 2024: 9 · 2023: 14 · 2022: 2 · 2021: 2
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • publish.UP (University of Potsdam) (submittedVersion, cc-by)
Funders
Helmholtz-Gemeinschaft (programme-oriented funding)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
human umbilical vein endothelial cells, nitric oxide release, prostacyclin, thromboxane B2, von Willebrand factor, extracellular matrix secretion, cell viability, membrane integrity
MeSH terms
Cardiovascular Diseases, Cells, Cultured, Endothelium, Vascular, Extracellular Matrix, Humans, Actin Cytoskeleton, Umbilical Arteries, von Willebrand Factor, Extracellular Matrix Proteins, Absorbable Implants, Tissue Engineering, Biomedical Research, Regenerative Medicine, Human Umbilical Vein Endothelial Cells, Cell- and Tissue-Based Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.